Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.
about
Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@en
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@nl
type
label
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@en
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@nl
prefLabel
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@en
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@nl
P2093
P2860
P356
P1476
Cefminox, a Dual Agonist of Pr ...... ulmonary Hypertension in Rats.
@en
P2093
Gulinuer Wumaier
Jingwen Xia
Liang Dong
Mengjie Niu
Shengli Zhang
Shengqing Li
Xiaomin Wei
P2860
P356
10.3389/FPHAR.2018.00134
P577
2018-02-23T00:00:00Z